The asbestos dilemma: I. Assessment of risk

Arhiv za Higijenu Rada i Toksikologiju

Volumn 53, Issue 2, 2002, Pages 153-167

  Valić, Fedor ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Amphiboles; Biopersistence; Chrysotile; Risk assessment; Thresholds

Indexed keywords

AMPHIBOLE; ASBESTOS; CHRYSOTILE;

ASBESTOSIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; HUMAN; MARKET; MATHEMATICAL MODEL; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; REVIEW; RISK ASSESSMENT;

ASBESTOS; ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; CARCINOGENS; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; RISK ASSESSMENT;

EID: 0036621926     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. US Environmental Protection Agency (EPA). Asbestos manufacture, importation, processing, and distribution in commerce prohibitions. Final Rule. Federal Register 1989; 54/132:29462-29513.
2. EU Commission Directive 91/659/EEC. Official Journal L.363.31/12/1991, p. 36-38.
3. EU Commission Directive 1999/77/EC. Official Journal L.207.06/08/1999, p. 18-20.
4. International Labour Organization (ILO). Asbestos recommendation, No. 172. Geneva: ILO, 1986.
5. Valić F. Asbestos and health. Local authorities, Health and Environment Briefing Series 25. Copenhagen: WHO Regional office for Europe, 1998.
6. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: a critical review. Industrial Health 1999;37(3):271-80.
7. International Programme on Chemical Safety/ World Health Organization (IPCS/WHO). Asbestos and other natural mineral fibres. Environmental Health Criteria 53. Geneva: WHO; 1986.
8. IARC Monographs on Evaluation of Carcinogenic Risks to Humans. Suppl. 7. Lyon: International Agency for Research on Cancer; 1987.
9. Commission of the European Communities (CEC). Official Journal of the European Communities, 1995;(C326/38).
10. World Health Organization (WHO). Guidelines for drinking water quality. Vol.2. Geneva: WHO; 1996.
11. Valić F, Beritiċ-Stahuljak D. Is chrysotile asbestos exposure a significant health risk to the general population? Central Eur J Publ Health 1993;1:26-30.
12. Collegium Ramazzini. Updating the epidemiology of asbestos disease. Proceedings, Annual Ramazzini Days. Med Lav 1995;86(5):388-500.
13. Peto J, Henderson BE, Pike MC. Trends in mesothelioma incidence and the forecast epidemic due to asbestos exposure during world war 11. In: Peto J, Schneiderman M, editors. Quantification of occupational cancer. Banbury Report 9. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1981. p. 51-72.
14. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:566-672.
15. Kjellstrom T, Smartt P. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. New Zealand Med J 2000;113:485-90.
16. Bourdes V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol 2000;16:411-7.
17. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of Frenchmen from mesothelioma. Occup Environ Med 2000;57:488-94.
18. Carbone M, Rizzo P, Pass H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 2000;20:875-7.
19. Coggon D. Occupational cancer in the United Kingdom. Environ Health Perspect 1999;107 (Suppl.2):239-44.
20. World Health Organization (WHO). A recommended method by phase-contrast optical microscopy (membrane filter method). Geneva: WHO; 1997.
21. Stanton MF, Layard D. The carcinogenicity of fibrous minerals. In: Proceedings of the Workshop on Asbestos: Definitions and Measurement Methods. Special publication 506. Washington (DC): US National Bureau of Standards; 1978. p. 143-151.
22. Pott F. Some aspects of the dosimetry and of carcinogenic potency of asbestos and other fibrous dusts. Staub-Reinhalt Luft 1978;38:486-90.
23. Walton WH. The nature, hazards and assessment of occupational exposure to airborne asbestos dust - a review. Ann Occup Hyg 1982;25:117-247.
24. Valić F, Skurić Z. Metodologija ocjenjivanja profesionalne izloženosti vlaknima azbesta [Methodology of the evaluation of occupational exposure to asbestos fibres, in Croatian]. Arh Hig Rada Toksikol 1988;39:169-81.
25. Kane AB, Boffetta P, Saracci R, Wilbourn JD, editors. Mechanisms of fibre carcinogenesis. 1ARC Scientific Publication No. 140. Lyon: International Agency for Research on Cancer; 1996.
26. Nicholson WJ, Landrigan PJ. The carcinogenicity of chrysotile asbestos. In: Mehlman MA, editor. Advances in modern environmental toxicology. Volume XXII. Princeton (NJ): Princeton Scientific Publication; 1994. p. 407-23.
27. Commission of the European Communities (CEC). Public health risks of exposure to asbestos. Bruxelles: CEC; 1977.
28. World Health Organization (WHO). Occupational exposure limits for asbestos. Geneva: WHO; 1989.
29. International Programme on Chemical Safety/ World Health Organization (IPCS/WHO). Reduction of asbestos in the environment (ICS/ 89.34.). Geneva: International programme on Chemical Safety; 1989.
30. Commission of the European Communities (CEC). Communication 426. Bruxelles: CEC; 1996.
31. International Programme on Chemical Safety/ World Health Organization (IPCS/WHO). Chrysotile asbestos. Environmental Health Criteria 203. Geneva: WHO; 1998.
32. American Conference of Governmental Industrial Hygienists (ACGIH). Occupational exposure limits 1995/1996. Cincinnati (OH): ACGIH; 1996.
33. Occupational Safety and Health Administration (OSHA). Occupational exposure to asbestos; Final Rule. Federal Register 1994;59:40964-41158.
34. American Conference of Governmental Industrial Hygienists (ACGIH). 2001 threshold limit values for chemical substances and physical agents & biological exposure indices. Cincinnati (OH): ACGIH; 2001.
35. Pravilnik o maksimalno dopustivim koncentracijama štetnih tvari u atmosferi radnih prostorija i prostora i o biološkim graničnim vrijednostima [Threshold limit values of hazardous materials in the air of work premises and biological threshold limits, in Croatian]. Narodne novine 1992/1993; (92):2088-111.
36. US Environmental Protection Agency (US EPA). Airborne asbestos health assessment update. EPA/600/8-84/003F. Washington (DC): Environmental protection Agency; 1986.
37. Dement JM, Wallingford KM. Comparison of phase contrast and electron microscopic methods for evaluation of occupational asbestos exposures. Appl Occup Environ Hyg 1990;5:242-7.
38. Dement JM, Brown DP, Okun A. Follow-up study of chrysotile asbestos textile workers: cohort mortality and case control analyses. Am J Ind Med 1994;26:431-47.
39. Dement JM, Brown DP. Lung cancer mortality among asbestos textile workers: a review and update. Ann Occup Hyg 1994;38:525-532.
40. Stayner L, Smith R, Bailer J et al. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med 1997;54:646-652.
41. LaDou J, Landrigan P, Bailer J, Foa V, Frank A on behalf of the Collegium Ramazzini. A call for an international ban on asbestos. Can Med Ass J 2001;20:489-490.
42. Berry G. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhalation Toxicol 1999;11:11-30.
43. Landrigan PJ, Nicholson WJ, Suzuki Y, LaDou J. The hazards of chrysotile asbestos: a critical review. Indust Health 1999;37:271-80.
44. Dement J. Differences in carcinogenicity between asbestos types. 2001 EPA Asbestos Health Effects Conference; May 2001; Oakland (CA) [cited 10 March 2002]. Available from URL: http:// www.epa.gov/swerrims/ahec/summary.htm
45. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565 601.
46. Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med 1996;30:252-66.
47. McDonald JC, Liddell FDK, Dufresne A, McDonald AD. The 1891-1920 birth cohort of Quebec chrysotile miners and millers: mortality 1976-1988. Br J Ind Med 1993;50:1072-81.
48. Liddel D. Cancer mortality in chrysotile mining and milling: exposure-response. Ann Occup Hyg 1994;38:519-23.
49. Gibbs GW, Valić F, Browne K, editors. Health risks associated with chrysotile asbestos. Ann Occup Hyg 1994;38:399-426.
50. McDonald JC, McDonald AD. Chrysotile, tremolite, and carcinogenicity. Ann Occup Hyg 1997;41:699-705.
51. McDonald AD, Case BW, Churg A et al. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg 1997;41:707-19.
52. Liddel FDK, McDonald AD, McDonald JC. The 1891-1920 birth cohort of Quebec chrysotile miners and millers - development from 1904 and mortality to 1992. Ann Occup Hyg 1997;41:13-36.
53. McDonald JC. Carcinogenicity of fibrous tremolite in workplace and general environments. 2001 EPA Asbestos Health Effects Conference; May 2001; Oakland (CA) [cited 10 March 2002]. Available from URL: http://www.epa.gov/swerrims/ahec
54. Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Indust Health 2001;39:150-60.
55. Valić F. Risk assessment of non -occupational asbestos exposure - can it be done? Arh Hig Rada Toksikol 1988;39:499-505.
56. Valić F. Some health aspects of environmental asbestos exposure. Proceedings of the AIA/NIOSH International Colloquium on Dust Measurement Techniques and Strategy. Budapest: National Institute of Occupational Health; 1991. p. 24-45.
57. Valić F. Influence of exposure conversions and activity-specific exposure-response relationships on the chrysotile asbestos risk assessment. In: Gibbs GW, Dunnigan J, Kido M, Higashi T, editors. Health risks from exposure to mineral fibres: an international perspective. North York (NY)-Ontario: Captus Press Inc., 1993. p. 129-35.
58. Berman DW. Assessing asbestos-related risk: new thinking/new protocol. 2001 EPA Asbestos Health Effects Conference; May 2001; Oakland (CA) [cited 10 March 2002]. Available from URL: http://www.epa.gov/swerrims/ahec
59. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9:1932-42.
60. Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cellul Physiol 1999;180:167-72.
61. Mayall FG, Jacobson G, Wilkins R. Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas. J Clin Pathol 1999;52:291.293.
62. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Nat Acad Sci 2000;97:10214-9.
63. Lebel J. Review of fibre concentrations in asbestos mines and Quebec asbestos mining towns. Sherbrooke: Quebec Asbestos Mining Association; 1995.
64. Robock K. Comparison of different measuring procedures in relation to conditions at the work place. In: Fischer M, Meyer E, editors. Assessment of the cancer risk from asbestos. BBA Schriften No2. 1984.
65. National Research Council, US National Academy of Sciences. Asbestiform fibers: non- occupational health risks. Washington, DC: National Academy Press, 1984.
66. US Environmental Protection Agency (US EPA). Regulatory impact analysis of controls on asbestos and asbestos products. Technical Report Vol. 1. Washington, DC: US EPA; 1988.
67. Berry G, Newhouse ML. Mortality of workers manufacturing friction materials using asbestos. Br J Indust Med 1983;40:1-7.
68. McDonald AD, Fry JC, Wooley AJ, McDonald JC. Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Indust Med 1984;41:151-7.
69. McDonald JC. Health implications of environmental exposure to asbestos. Environ health Perspect 1985;62:319-28.
70. Valić F. Asbestos risk in vehicle manufacture, maintenance and repair. In: Reduction of asbestos in the environment. Geneva: International Programme on Chemical Safety/World Health Organization, 1989, 73-99.
71. World Health Organization Regional Office for Europe (WHO/Europe). Asbestos. Final meeting on air quality guidelines for the European region. Copenhagen: WHO/Europe; 1986.
72. World Health Organization (WHO). Guidelines for drinking water quality, Geneva: WHO; 1984.
73. World Health Organization (WHO). Air quality guidelines for Europe. WHO Regional Publications, European Series No. 23. Copenhagen: WHO/ Europe; 1987.